Results of General Meeting 5 May 2009
Results of General Meeting of Members ...
Convertible Notes Resolved
MTY has finalised an agreement with holders of MTY Convertible Notes ...
MTY Shareholder News October 2008
MTY Shareholder News
Midkine Test Validated
... Revenue Generating Veterinary Midkine Test Validated....
Major US Patent Granted
...“Agents Comprising Midkine or an Inhibitor Thereof as Active Ingredient”...
Removal of $1.5M potential liability
MTY and Cell Signals Inc., have signed an amendment to the IP Agreement
Analyst Report and Interactive Roadshow Released
... first online Interactive Investor Roadshow eKit ...
Midkine Strategy
...MTY completed its Midkine Commercial Developement Strategy...


Cellmid Ltd (CDY):

Last Price

ASX Announcement - Convertible Notes Resolved

Medical Therapies Limited has finalised an agreement with holders of MTY Convertible Notes (Noteholders) which has resulted in the successful amendment of the Convertible Note Deed Poll.

Note holders will be issued 2.55 ordinary shares and be paid 6.8 cents cash for each Convertible Note currently held. These amendments are to be implemented on or before 25th February 2009.


To read more.... Download pdf here

© Cellmid Ltd
Share Trading Policy | Privacy | Contact Us
Web Developer Sydney
 Web design company
Cellmid Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@cellmid.com.au